DXT: Injector And Syringe, Angiographic
What it covers
An angiographic injector and syringe is a device that consists of a syringe and a high-pressure injector which are used to inject contrast material into the heart, great vessels, and coronary arteries to study the heart and vessels by x-ray photography.
The identification in 21 CFR 870.1650, angiographic injector and syringe. FDA gives DXT no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262043 | MEDRAD® MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD® IS12 Module (IS12); MEDRAD® Imaging Bulk Package Transfer Spike | Bayer Medical Care, Inc. | Oct 6, 2026 | Traditional |
| K252652 | Disposable Syringes with Accessories for Power Injectors (900103T); Disposable Syringes with Accessories for Power Injectors (900103H); Disposable Syringes with Accessories for Power Injectors (801800H); Disposable Syringes with Accessories for Power Injectors (800099T); Disposable Syringes with Accessories for Power Injectors (800099H); Disposable Syringes with Accessories for Power Injectors (800096T); Disposable Syringes with Accessories for Power Injectors (800096H); Disposable Syr | Fortis Biosolutions Company Limited | May 14, 2026 | Traditional |
| K252638 | VeraPro S100 Multi-Use Syringe (018808); VeraPro S100 LV1 Low Viscosity Single-Use Syringe (018811); VeraPro AMT Auto-Manifold and Transducer (018814); VeraPro AngioTouch FLX165 Hand Controller Kit (018806); VeraPro AngioTouch HiFi165 Hand Controller Kit (018804) | Acist Medical Systems, Inc. | May 13, 2026 | Traditional |
| K252653 | ACIST Pro Diagnostic System (019304); Processing Unit Bed Mount; AngioTouch Module; ACIST Pro Cart; Single Transducer Cable; Triple Transducer Cable | Acist Medical Systems, Inc. | May 13, 2026 | Traditional |
| K253048 | High Pressure Syringe; Pressure Connecting Tube; Quick fill tube; Spike; Transfer Tube | Shenzhen Maiwei Biotech Co., Ltd. | Apr 16, 2026 | Traditional |
| K251788 | Extension tube | Zhuhai DR Medical Instruments Co., Ltd. | Mar 5, 2026 | Traditional |
| K252891 | MEDRAD MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD ISI2 Module (ISI2) | Bayer Medical Care, Inc. | Feb 13, 2026 | Traditional |
| K244038 | High Pressure Tubing | Shandong Int Medical Instruments Co., Ltd. | Sep 5, 2025 | Traditional |
| K242143 | Angiography Injector | Shandong Int Medical Instruments Co., Ltd. | Dec 23, 2024 | Traditional |
| K242212 | Disposable Syringe (Kit); Nemoto Disposable Syringe (Kit) | Nemoto Kyorindo Co., Ltd. | Aug 27, 2024 | Traditional |
Clearances by year
64 DXT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 7 | 264 |
| 2025 | 1 | 249 |
| 2024 | 4 | 138 |
| 2023 | 1 | 104 |
| 2021 | 1 | 152 |
| 2020 | 3 | 154 |
| 2019 | 4 | 96 |
| 2018 | 9 | 93 |
| 2017 | 7 | 183 |
| 2016 | 8 | 172 |
| 2015 | 7 | 153 |
| 2014 | 6 | 144 |
| 2013 | 2 | 265 |
| 2011 | 4 | 69 |
Who submits
26 applicants cleared a DXT device since 2011. 70% of the clearances went to applicants in United States, then China (23%), Japan (5%) and Taiwan (2%). By type: Traditional 73%, Special 25% and Abbreviated 2%. 2 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Osprey Medical, Inc. | 14 |
| Bayer Medical Care, Inc. | 8 |
| Coeur, Inc. | 7 |
| Acist Medical Systems, Inc. | 5 |
| Nemoto Kyorindo Co., Ltd. | 3 |
| Shenzhen Boon Medical Supply Co., Ltd. | 3 |
| Medrad, Inc. | 2 |
| Merit Medical Systems, Inc. | 2 |
How FDA classifies it
Class II (special controls). The device, when it is a non-patient contacting balloon inflation syringe intended only to inflate/deflate balloon catheters and monitor pressure within the balloon, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
From 21 CFR 870.1650. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 870.1650 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DXT clearances declared.
Ask about DXT
Questions about DXT
What is FDA product code DXT?
Product code DXT, “Injector And Syringe, Angiographic” in FDA's classification database, is a Class II device type under 21 CFR 870.1650 (angiographic injector and syringe), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 211 clearances under DXT, 64 of them since 2011.
How many 510(k) clearances are there under DXT?
FDA’s 510(k) database listed 211 clearances under DXT as of Oct 29, 2026, 64 of them decided since 2011; the most recent decision was Oct 6, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DXT 510(k)?
For the 9 DXT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 249 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DXT clearances?
Since 2011: Osprey Medical, Inc. (14), Bayer Medical Care, Inc. (8), Coeur, Inc. (7), Acist Medical Systems, Inc. (5) and Nemoto Kyorindo Co., Ltd. (3). 26 applicants have cleared a DXT device in that time.